We are live on
!
Find out more
Boston Partners Portfolio holdings
AUM
$113B
Turnover
18.52%
1-Year Est. Return
38.87%
This Fund
S&P 500
This Quarter
Est. Return
+0.94%
1 Year Est. Return
+38.87%
3 Year Est. Return
+108.29%
5 Year Est. Return
+142.95%
10 Year Est. Return
+500.61%
AUM
$67.9B
AUM Growth
-$1.92B
(-2.7%)
Cap. Flow
-$1.61B
Cap. Flow
% of AUM
-2.37%
Top 10 Holdings %
Top 10 Hldgs %
16.65%
Holding
792
New
60
Increased
302
Reduced
281
Closed
78
Avg Time Held
1.7
years
Top 10 Avg Time Held
1.8
years
Top 20 Avg Time Held
1.3
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bank of America
BAC
|
+$761M |
| 2 |
PPG Industries
PPG
|
+$342M |
| 3 |
Pultegroup
PHM
|
+$278M |
| 4 |
Apple
AAPL
|
+$233M |
| 5 |
UnitedHealth
UNH
|
+$211M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$701M |
| 2 |
Medtronic
MDT
|
+$355M |
| 3 |
Lockheed Martin
LMT
|
+$309M |
| 4 |
TOWERS WATSON & CO COM STK CL A (DE)
TW
|
+$286M |
| 5 |
Western Digital
WDC
|
+$252M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 26.4% |
| 2 | Technology | 13.5% |
| 3 | Healthcare | 12.95% |
| 4 | Industrials | 11.68% |
| 5 | Energy | 8.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
BMCH
301
DELISTED
BMC Stock Holdings, Inc
BMCH
| $18.7M | 0.03% |
1,127,926
+7,312
| +0.7% | +$107K |
2013 Q3
10 quarters
|
|
302
Stagwell
STGW
$2.23B
| $18.7M | 0.03% |
793,580
-447,130
| -36% | -$9.06M |
2013 Q2
11 quarters
|
|
|
EXAR
303
DELISTED
Exar Corporation
EXAR
| $18.4M | 0.03% |
3,204,450
-632,166
| -16% | -$3.41M |
2013 Q2
11 quarters
|
|
304
Nu Skin
NUS
$254M
| $18.4M | 0.03% |
480,983
-1,843
| -0.4% | -$61K |
2013 Q2
11 quarters
|
|
305
Morgan Stanley
MS
$286B
| $18.3M | 0.03% |
731,777
-172,939
| -19% | -$4.41M |
2015 Q3
2 quarters
|
|
306
Cabot Corp
CBT
$3.9B
| $18.2M | 0.03% |
377,170
-8,055
| -2% | -$347K |
2013 Q2
11 quarters
|
|
307
Teradyne
TER
$53.7B
| $18M | 0.03% |
835,071
-28,694
| -3% | -$561K |
2013 Q2
11 quarters
|
|
|
ISBC
308
DELISTED
Investors Bancorp, Inc.
ISBC
| $18M | 0.03% |
1,545,559
-1,179,961
| -43% | -$13.6M |
2014 Q2
7 quarters
|
|
|
STBZ
309
DELISTED
State Bank Financial Corporation. Common Stock
STBZ
| $17.8M | 0.03% |
900,120
-127,140
| -12% | -$2.47M |
2014 Q4
5 quarters
|
|
310
Assured Guaranty
AGO
$3.07B
| $17.6M | 0.03% |
694,546
-5,734
| -0.8% | -$141K |
2015 Q2
3 quarters
|
|
311
FTI Consulting
FCN
$4.04B
| $17.5M | 0.03% |
492,582
+7,611
| +2% | +$255K |
2013 Q2
11 quarters
|
|
312
DELISTED
Onebeacon Insurance Group Ltd
OB
| $17.4M | 0.03% |
1,363,550
+65,372
| +5% | +$835K |
2013 Q2
11 quarters
|
|
313
DELISTED
Select Medical
SEM
| $17.3M | 0.03% |
2,726,232
+21,684
| +0.8% | +$116K |
2013 Q2
11 quarters
|
|
|
FTD
314
DELISTED
FTD Companies, Inc. Common Stock
FTD
| $17.3M | 0.03% |
658,838
+4,234
| +0.6% | +$103K |
2014 Q1
8 quarters
|
|
|
KND
315
DELISTED
Kindred Healthcare
KND
| $17.1M | 0.03% |
1,382,032
+5,156
| +0.4% | +$53.5K |
2013 Q2
11 quarters
|
|
316
WaFd
WAFD
$2.18B
| $17M | 0.03% |
751,782
+7,993
| +1% | +$173K |
2013 Q2
11 quarters
|
|
317
FreightCar America
RAIL
$201M
| $17M | 0.03% |
1,088,440
+211,310
| +24% | +$3.65M |
2013 Q4
9 quarters
|
|
318
Insight Enterprises
NSIT
$4.66B
| $16.9M | 0.02% |
588,648
-7,298
| -1% | -$184K |
2013 Q2
11 quarters
|
|
319
Customers Bancorp
CUBI
$2.51B
| $16.6M | 0.02% |
701,398
-219,633
| -24% | -$5.25M |
2013 Q2
11 quarters
|
|
320
DELISTED
Gramercy Property Trust
GPT
| $16.5M | 0.02% |
650,913
-43,232
| -6% | -$971K |
2013 Q4
9 quarters
|
|
|
KNL
321
DELISTED
Knoll, Inc.
KNL
| $16.4M | 0.02% |
758,009
+3,973
| +0.5% | +$74.6K |
2013 Q2
11 quarters
|
|
322
HCA Healthcare
HCA
$101B
| $16.4M | 0.02% |
209,703
+116,803
| +126% | +$8.16M |
2014 Q4
5 quarters
|
|
|
LHO
323
DELISTED
LaSalle Hotel Properties
LHO
| $16.3M | 0.02% |
645,447
+442,177
| +218% | +$10.5M |
2015 Q1
4 quarters
|
|
324
Viper Energy
VNOM
$8.5B
| $16.2M | 0.02% |
994,831
+59,299
| +6% | +$891K |
2014 Q3
6 quarters
|
|
325
DELISTED
Equity Commonwealth
EQC
| $16.2M | 0.02% |
572,860
-83,980
| -13% | -$2.27M |
2015 Q2
3 quarters
|
|
Similar funds
Boston Partners's Q1 2016 Portfolio in Review
As of Q1 2016, Boston Partners held 792 positions worth $67.9B, down 2.7% from $69.8B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Boston Partners's Q1 2016 filing shows 60 new, 302 increased, 281 reduced and 78 closed positions. Its largest new stake was Pultegroup: 16,274,531 shares worth $304M. The largest sale was Pfizer, an estimated $701M.
By sector, the portfolio is most concentrated in Financials at 26% of assets, down from 27% a quarter earlier, followed by Technology and Healthcare.
- Boston Partners's largest Q1 2016 buy was Pultegroup: 16,274,531 shares worth $304M.
- Boston Partners added most to Bank of America in Q1 2016, an estimated $761M increase.
- Boston Partners's biggest Q1 2016 reduction was Pfizer, cutting an estimated $701M.
- Boston Partners fully exited TOWERS WATSON & CO COM STK CL A (DE) in Q1 2016, selling an estimated $286M.
- Boston Partners's ten largest holdings make up 17% of its $67.9B portfolio in Q1 2016.
- Boston Partners opened 60 new positions and closed 78 in Q1 2016.
- Boston Partners's portfolio value fell 2.7% quarter-over-quarter to $67.9B.
Based on Boston Partners's 13F filing for Q1 2016, filed 12 May 2016.